Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 12, 2026 · Filed Nov 14, 2026
Vivani Medical's Chief Business Officer paid $15K out of pocket for Vivani Medical shares. It was the first purchase in 19 months. Shares held went up 25% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$15,495
Shares × reported transaction price
<$25K
+25.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 19 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 5 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals about 2.1% of the average reported total pay of the company's named executive officers other than the CEO, fiscal 2025 ($751K)
An average across the officers named in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-04-29. This person may not be one of them, so it is not their own pay. A size comparison, not a judgement
on the day of results (Nov 12, 2026)
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $0.9834 on Nov 12, 2026, within 5% of its 52-week low, after a 19% drop over the previous 30 trading days
52-week range $0.938 (Mar 30, 2026) to $1.60 (Jul 8, 2026), 7% of the way up, from 251 adjusted closes. 30 trading days earlier: $1.22 on Oct 1, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Donald Dwyer's largest purchase of VANI in their filings since 2022
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Insider buying
Traded Nov 12 · filed 2 days later
Vivani Medical's Chief Business Officer paid $4.2K out of pocket for Vivani Medical shares. It was the first purchase in 19 months. Shares held went up 9% with this purchase.
Insider filing
Traded Oct 15 · filed 4 days later
Gift or transfer — classified separately from trades.
Donald Dwyer, Chief Business Officer's past purchases, 90 days after disclosure: 3 buys, median +10.5 pts vs S&P 500, beat it 3 of 3 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.